| |
Wednesday, February 23, 2005
Information Gathering Session
|
| |
I. |
|
Welcome and Participant Introductions
Dr. Michael Falk, Executive Director
|
| |
II. |
|
Background Information on LSRO
Dr. Michael Falk
|
| |
III. |
|
Introduction to Project
Dr. Catherine St. Hilaire, Project Leader
|
| |
IV. |
|
Tobacco Harm Reduction
| a. | Overview of Clearing the Smoke
Dr. Kathleen Stratton
Institute of Medicine |
| b. | Overview of NIH Research Initiatives
Dr. Mark Parascandola
Tobacco Control Research Branch
National Cancer Institute |
|
| |
V. |
|
Discussion Period
|
| |
| |
Lunch |
| |
VI. |
|
Luncheon speaker: Dr. Daniel Byrd III
Summary of LSRO Added Ingredients Review, Phases I & II
|
| |
| |
Executive Session
|
| |
VII. |
|
Committee Discussion of LSRO Guidelines for Risk-Related Projects
|
| |
VIII. |
|
Charge to the Committee
Dr. Catherine St. Hilaire
|
| |
IX. |
|
Literature Review and Evaluation
Dr. Amy Brownawell
|
| |
X. |
|
Discussion of Terminology, Definitions and Principles
Dr. Catherine St. Hilaire
|
| |
| |
Thursday, February 24, 2005
Executive Session |
| |
I. |
|
Evaluative [Risk Assessment] Process
Dr. Catherine St. Hilaire
|
| |
II. |
|
Biological Effects Assessment
Dr. Amy Brownawell
|
| |
III. |
|
Exposure Assessment
Dr. Kara Lewis
|
| |
IV. |
|
Exposure Assessment (Population)
Dr. Keith Lenghaus
|
| |
V. |
|
Characterization of Exposure/Risk/Harm Reduction
Dr. Catherine St. Hilaire
|
| |
VI. |
|
Case Study
Project Staff
|
| |
VII. |
|
Next Steps
| a. |
March Meeting |
| b. |
Assignments |
| c. |
Discussion of SOSR Committees |
| d. |
Other |
|
